김남훈 교수의 진료시간표

김남훈 교수의 상세정보

•  ~  2004  :  고려대학교 의과대학 졸업
•  ~  2009  :  고려대학교 의과대학 대학원 석사
•  ~  2015  :  고려대학교 의과대학 대학원 박사

• 2012  ~  2013  :  고려대학교 안암병원 내분비내과 임상강사
• 2014  ~  2016  :  고려대학교 안암병원 내분비내과 임상조교수
• 2016  ~  2018  :  고려대학교 안암병원 내분비내과 조교수
• 2019  ~  2020  :  UCSD 연수
• 2018  ~   :  고려대학교 안암병원 내분비내과 부교수

• 2013  :  고려대학교 의과대학 교우회 학내지부 우수 논문상
• 2015  :  대한당뇨병학회 춘계학술대회 우수 포스터 구연상
• 2017  :  Seoul International Congress of Endocrinology and Metabolism 2017 우수 구연상
• 2017  :  대한내분비학회 연구상
• 2017  :  대한내분비학회 EnM 학술상
• 2018  :  Seoul International Congress of Endocrinology and Metabolism 2018 우수 구연상
• 2018  :  Diabetes & Metabolism Journal 우수논문상
• 2018  :  대한내분비학회 신진연구자상
• 2019  :  Diabetes & Metabolism Journal 우수논문상
• 2020  :  대한당뇨병학회 Young Investigator Award (한독학술상)

•  ~   :  대한당뇨병학회 정회원
•  ~   :  대한내분비학회 정회원
•  ~   :  대한비만학회 정회원
•  ~   :  Asian Association for the Study of Diabetes 정회원
•  ~   :  미국 당뇨병 학회 정회원
• 2017 .01  ~  2018 .12  :  대한내분비학회 학술위원회 간사
• 2018 .01  ~  2019 .12  :  대한당뇨병학회 기획위원회 간사
• 2019 .01  ~   :  대한비만학회 연구위원회 위원
• 2020 .01  ~   :  대한당뇨병학회 진료지침위원회 위원
• 2021 .01  ~   :  대한내분비학회 기획위원회 간사
• 2021 .01  ~   :  한국지질동맥경화학회 간행위원회 위원

• [SCI] (A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: A comparison with a nationwide survey in Japan)
• [SCI] (A patient with micropapillary thyroid carcinoma and macronodular lung metastasis: Stable disease for eight years without treatment)
• [SCI] (Depression is associated with sarcopenia, not central obesity, in elderly Korean men)
• [SCI] (Short sleep duration combined with obstructive sleep apnea is associated with visceral obesity in Korean adults)
• [SCI] (Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial)
• [국내논문] DPP-4 억제제의 비교(Comparison of DPP-4 inhibitors)
• [SCI] (Clinical and Metabolic Factors Associated with Development and Regression of Nonalcoholic Fatty Liver Disease in Nonobese Subjects)
• [SCI] (Age-related differences in diabetes care outcomes in Korea: a retrospective cohort study)
• [SCI] (Body Mass Index and Mortality in the General Population and in Subjects with Chronic Disease in Korea: A Nationwide Cohort Study (2002-2010))
• [SCI] (Vitamin D status and associated metabolic risk factors among North Korean refugees in South Korea: a cross-sectional study)
• [국내논문] (Editorial: Cancer survivors at risk of metabolic disorder)
• [국내논문] (Primary hyperparathyroidism with extensive brown tumors and multiple fractures in a 20-year-old woman)
• [국내논문] (Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy)
• [SCI] (Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice)
• [SCI] (Relative and combined effects of socioeconomic status and diabetes on mortality: A nationwide cohort study.)
• [SCI] (Letter: Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93).)
• [SCI] (Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke)
• [국내논문] (Lessons from recent cardiovascular outcome trials of type 2 diabetes)
• [국내논문] (Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study)
• [SCI] (Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus)
• [국내논문] Dipeptidyl Pepdiase-4 억제제와 Sodium Glucose Cotransporter 2 억제제의 새로운 안전성 이유: 어떻게 해석하고 진료현장에 적용할 것인가?
• [SCI] (Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model)
• [SCI] (Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study)
• [SCI] (10-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013.)
• [SCI] (Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial)
• [SCI] (A novel central adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality: proposal and validation)
• [SCI] (Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study)
• [국내논문] (Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis)
• [SCI] (Diabetes Mellitus, Still Major Threat to Mortality from Various Causes)
• [SCI] (Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study)
• [SCI] (Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials)
• [SCI] (Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction)
• [SCI] (Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults)
• [SCI] (Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study)

• 당뇨병학 교과서 (5판)

최종수정일 : 2020.09.14